NVS
As of 2026-11-06, Novartis AG (NVS) has a market capitalization of $309.21 B, making it the #38 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-11-06 | $309.21 B |
| 2026-11-05 | $308.99 B |
| 2026-11-04 | $314.20 B |
| 2026-11-03 | $303.51 B |
| 2026-11-02 | $308.20 B |
| 2026-11-01 | $306.81 B |
| 2026-10-31 | $306.81 B |
| 2026-10-30 | $309.10 B |
| 2026-10-29 | $307.40 B |
| 2026-10-28 | $297.60 B |
| 2026-10-27 | $299.21 B |
| 2026-10-26 | $293.49 B |
As of 2026-11-06, Novartis AG (NVS) has a market capitalization of $309.21 B, making it the #38 most valuable US-listed company.
Novartis AG is the #38 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-10-25 | $288.36 B |
| 2026-10-24 | $288.36 B |
| 2026-10-23 | $288.36 B |
| 2026-10-22 | $298.32 B |
| 2026-10-21 | $293.72 B |
| 2026-10-20 | $293.17 B |
| 2026-10-19 | $287.23 B |
| 2026-10-18 | $287.41 B |
| 2026-10-17 | $287.41 B |
| 2026-10-16 | $287.41 B |
| 2026-10-15 | $286.92 B |
| 2026-10-14 | $280.27 B |
| 2026-10-13 | $271.74 B |
| 2026-10-12 | $274.47 B |
| 2026-10-11 | $274.30 B |
| 2026-10-10 | $274.30 B |
| 2026-10-09 | $274.30 B |
| 2026-10-08 | $273.08 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.